Latest Health News
Singapore Tightens Public Health Measures for Measles from April 1 After 12 New Cases
Singapore's Communicable Diseases Agency announced enhanced measures starting April 1, 2026, following 12 new measles cases reported between February 1 and March 24. Eleven cases were among unvaccinated individuals, including two infants, with no evidence of wider community spread. The agency aims to maintain herd immunity amid global rises.
2026 Canada Gairdner Awards Honor Scientists for Breakthroughs in Human Health
The Gairdner Foundation announced nine laureates for pioneering work in biomedical and global health research. Awards recognize transformative discoveries impacting diseases from cholera to spinal cord injuries. These honors highlight global advancements in treatment and prevention.
John Dirks Global Health Award for Oral Cholera Vaccine Development
Prof. John D. Clemens and Jan Holmgren received the award for developing affordable oral cholera vaccines like Shanchol. Their research enabled WHO recommendations, global stockpiles, and significant reductions in cholera cases worldwide. Millions of doses have been distributed, saving lives in outbreak areas.
Momentum Award for Spinal Cord Injury Blood Pressure Therapy
Aaron Phillips earned the Peter Gilgan Canada Gairdner Momentum Award for a therapy restoring stable blood pressure post-spinal cord injury. Clinical studies show it reduces medication needs and enables better daily function, with FDA Breakthrough Designation. It affects over 27 million people globally.
NHS England Set to Miss Key March 2026 Waiting Time Targets
The NHS is projected to miss 65% elective care within 18 weeks and 78% A&E four-hour targets. Only one in three trusts met elective goals in January, with February A&E at 74.1%. New GP referral quotas aim to reduce lists.
Eli Lilly Demands Higher NHS Drug Prices for UK Investment Resumption
Eli Lilly will resume UK investment only if NHS agrees to drug price increases and ends a £1.8 billion rebate scheme. Talks with ministers are progressing positively toward a summer agreement. This impacts medicine affordability and industry investment.
UK Government Pilot Reduces Musculoskeletal Waiting Times by 20%
A £3.5 million NHS pilot in 17 high-wait areas cut 18-week MSK lists by 20% from December 2024 to March 2025. Digital tools and one-day clinics enabled 7,500 quicker treatments. It addresses long community waits for musculoskeletal issues.
Notre Dame Joins UN CSW70 Forum on Women's and Girls' Health Challenges
University of Notre Dame academics and students presented at a virtual IHAN forum on refugee health, climate change, and gender violence. Over 100 attendees discussed Global Burden of Disease and UN SDGs for women. It highlighted interprofessional solutions for global pressures.
ENDRA Life Sciences Reports 2025 Results and Evaluates Strategic Alternatives
ENDRA, focusing on thermoacoustic imaging for steatotic liver disease, announced Q4 and full-year 2025 financials. The board initiated strategic alternatives review on March 25, 2026. It advances early detection tech amid liver health needs.
Forte Biosciences Announces 2025 Results and FB102 Celiac Study Update
Forte Biosciences reported 2025 financials, with Phase 2 celiac disease study topline results expected in 2026. FB102 targets autoimmune diseases, progressing clinical development. CEO optimistic on key readouts ahead.
Concerns Persist Over UK Care Quality Commission Reforms
CQC consultation reveals low confidence and wariness after failed past reforms. Plans to change the single assessment framework from October 2025 face skepticism. It impacts oversight of health and care quality.
Coffee Consumption Linked to 35% Lower Dementia Risk
Two to three cups of coffee daily may protect against dementia by 35%, per new research. This simple habit shows potential brain health benefits. Moderation is key for optimal effects.